drugset
drugset / Trial / NCT00796900

Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)

NCT00796900 ↗

Phase 2/3 Terminated 34 enrolled Medical University of Vienna
RandomizedParallel-groupTriple-blindTreatment

Summary

Dantrolene is used to prevent hyperthermia in intensive care patients suffering from subarachnoidal hemorrhage.

Timeline

Start
2008-05
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dantrolene Small molecule 5 mg/kg Intravenous

Indications

No indication recorded.